.Innovent Biologics has created the scenario that its checkpoint inhibitor-cytokine blend protein ha...
.A phase 3 trial of Daiichi Sankyo and Merck & Co.'s HER3-directed antibody-drug conjugate (ADC) ...
.Five months after Rakovina Therapies rotated towards expert system, the cancer-focused biotech has ...
.Ascendis Pharma has actually become a prospective risk to BioMarin's Voxzogo, stating phase 3 devel...
.Though Alkeus Pharmaceuticals' oral eye disease property fell short to substantially lower geograph...
.With a triad of biotechs attacking the Nasdaq on Friday, it was actually effortless to miss a small...
.Immune checkpoint inhibitors are the superheroes of cancer cells treatment. Medicines like Bristol ...
.Invite to recently's Chutes & Ladders, our summary of considerable management hirings, firings a...
.Regeneron is back with long-lasting follow-up for its LAG-3 prevention and also PD-1 prevention com...
.AstraZeneca has actually shared a very early look at the performance of its own internal antibody-d...